Seeking Alpha

Premiums are rising on healthcare deals, as drug companies scramble to secure a narrowing field...

Premiums are rising on healthcare deals, as drug companies scramble to secure a narrowing field of companies with viable prospects. There's a "panicky quality to deals" now, says one I-banker, and premiums may be forced even higher as competition among buyers intensifies.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|